Validation of biomarkers in humans exposed to benzene: Urine metabolites
โ Scribed by Qingshan Qu; Assieh A. Melikian; Guilan Li; Roy Shore; Lungchi Chen; Beverly Cohen; Songnian Yin; Mark R. Kagan; Heyi Li; Min Meng; Ximei Jin; Witold Winnik; Yuying Li; Ruidong Mu; Keqi Li
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 166 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0271-3586
No coin nor oath required. For personal study only.
โฆ Synopsis
Background The present study was conducted among Chinese workers employed in glue-and shoe-making factories who had an average daily personal benzene exposure of 31 AE 26 ppm (mean AE SD). The metabolites monitored were S-phenylmercapturic acid (S-PMA), trans, trans-muconic acid (t,t-MA), hydroquinone (HQ), catechol (CAT), 1,2,4trihydroxybenzene (benzene triol, BT), and phenol. Methods S-PMA, t,t-MA, HQ, CAT, and BT were quantiยฎed by HPLC-tandem mass spectrometry. Phenol was measured by GC-MS. Results Levels of benzene metabolites (except BT) measured in urine samples collected from exposed workers at the end of workshift were signiยฎcantly higher than those measured in unexposed subjects (P `0.0001). The large increases in urinary metabolites from before to after work strongly correlated with benzene exposure. Concentrations of these metabolites in urine samples collected from exposed workers before work were also signiยฎcantly higher than those from unexposed subjects. The half-lives of S-PMA, t,t-MA, HQ, CAT, and phenol were estimated from a time course study to be 12.8, 13.7, 12.7, 15.0, and 16.3 h, respectively. Conclusion All metabolites, except BT, are good markers for benzene exposure at the observed levels; however, due to their high background, HQ, CAT, and phenol may not distinguish unexposed subjects from workers exposed to benzene at low ambient levels. S-PMA and t,t-MA are the most sensitive markers for low level benzene exposure. Am.
๐ SIMILAR VOLUMES
Fhoromethylene-rn-tyrosine (FMMT, MDL 72394) represents a prodrug approach to site-selective, irreversible inhibition of monoamine oxidase. A sensitive and specific method for the quantification of FMMT and its active metabolite (MDL 72392) in human plasma and urine has been developed for future pha